The 6th mRNA‑Based Therapeutics Summit: Accelerating the Next Era of mRNA Medicines

The global mRNA landscape is advancing at unprecedented speed, propelled by scientific breakthroughs and high‑impact biopharma investment. Recent acquisitions – including Eli Lilly and Orna, BMS and Orbital, AbbVie and Capstan, and BioNTech and CureVac – underscore the momentum behind emerging modalities such as in vivo CAR‑T, gene editing, and cancer immunotherapies as they move closer to clinical validation and commercial potential.

Amid this rapid evolution, the 6th mRNA‑Based Therapeutics Summit returns to Boston this summer as the world’s most influential meeting dedicated to mRNA science and drug development. Bringing together 350+ global leaders from established pharma innovators to trailblazing start‑ups – including Moderna, Pfizer, AstraZeneca, Sanofi, ParcelBio, CaVos Therapeutics and Kernal Biologics – as well as regulators from the US FDA, MHRA and EMA, the summit serves as the central forum shaping the future of mRNA technology.

This year’s revitalized agenda spans three core tracks – Discovery, Pre‑Clinical & Clinical Development, and Manufacturing & CMC – while introducing two brand‑new focus days on AI‑Driven mRNA Design and Next‑Generation Delivery Technologies. Across scientific sessions, case studies, and collaborative discussions, attendees will gain exclusive access to emerging data, regulatory expectations, and the partnerships driving mRNA toward its next frontier.

With 1,988 mRNA assets currently moving through global pipelines, the field is scaling faster than ever. The 2026 summit is strategically timed to spotlight major advancements across linear, circular, and self‑amplifying RNA platforms; next‑generation vaccine innovation and expanding clinical progress in oncology, rare diseases, autoimmune conditions, and beyond.

As the flagship global gathering for mRNA innovators, this summit remains the definitive place to connect with key decision makers, forge new strategic partnerships, and refine development and delivery strategies. From protein replacement to cell and gene therapeutics and transformative delivery technologies, the 6th mRNA‑Based Therapeutics Summit equips teams with the insights, networks, and momentum needed to accelerate candidates to clinical and commercial success and ultimately deliver life‑changing medicines to patients worldwide.

To know more visit: https://ter.li/axdw1v